Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian W Bigger

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Molecular Genetics and Metabolism|August 27, 2018
Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disordersBrian W Bigger, David J Begley, Daniela Virgintino, et al.
Plos One|February 17, 2017
Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type IIHélène F E Gleitz, Claire O'Leary, Rebecca J Holley, et al.
Molecular Genetics and Metabolism|November 21, 2009
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB miceKia Langford-Smith, Malani Arasaradnam, J Ed Wraith, et al.
Journal of Inherited Metabolic Disease|May 9, 2013
Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunityLouise D Archer, Kia J Langford-Smith, Brian W Bigger, et al.
Human Gene Therapy|July 10, 2023
Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral DiseaseOriana Mandolfo, Aiyin Liao, Esha Singh, et al.
Plos One|September 19, 2018
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapyAbhijit Ricky Pal, Jean Mercer, Simon A Jones, et al.
European Journal of Haematology|March 24, 2007
Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cellsElena K Siapati, Brian W Bigger, Karl Kashofer, et al.
Journal of Inherited Metabolic Disease|July 10, 2012
Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)Louise D Archer, Kia J Langford-Smith, William R Critchley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2013
Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiationFiona L Wilkinson, Ana Sergijenko, Kia J Langford-Smith, et al.
Behavioural Brain Research|February 9, 2010
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIBMaria M Canal, Fiona L Wilkinson, Jonathan D Cooper, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Molecular Genetics and Metabolism|August 27, 2018
Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disordersBrian W Bigger, David J Begley, Daniela Virgintino, et al.
Plos One|February 17, 2017
Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type IIHélène F E Gleitz, Claire O'Leary, Rebecca J Holley, et al.
Molecular Genetics and Metabolism|November 21, 2009
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB miceKia Langford-Smith, Malani Arasaradnam, J Ed Wraith, et al.
Journal of Inherited Metabolic Disease|May 9, 2013
Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunityLouise D Archer, Kia J Langford-Smith, Brian W Bigger, et al.
Human Gene Therapy|July 10, 2023
Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral DiseaseOriana Mandolfo, Aiyin Liao, Esha Singh, et al.
Plos One|September 19, 2018
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapyAbhijit Ricky Pal, Jean Mercer, Simon A Jones, et al.
European Journal of Haematology|March 24, 2007
Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cellsElena K Siapati, Brian W Bigger, Karl Kashofer, et al.
Journal of Inherited Metabolic Disease|July 10, 2012
Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)Louise D Archer, Kia J Langford-Smith, William R Critchley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2013
Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiationFiona L Wilkinson, Ana Sergijenko, Kia J Langford-Smith, et al.
Behavioural Brain Research|February 9, 2010
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIBMaria M Canal, Fiona L Wilkinson, Jonathan D Cooper, et al.
Pageof 7